Phase II study of mitomycin, doxorubicin, and cisplatin in the treatment of advanced uterine leiomyosarcoma: a Gynecologic Oncology Group study.

Source:http://linkedlifedata.com/resource/pubmed/id/12051882

Download in:

View as

General Info

PMID
12051882